Patricia Doris Cherasard, RPAC

Patricia Cherasard practices at NYU Langone Hospitals - Long Island in Mineola, New York.

Patricia Cherasard's NPI, 1104889666, was assigned on April 7, 2006. Patricia Cherasard holds New York license 006429.

Patricia Cherasard's primary practice is NYU Langone Hospitals - Long Island, at 259 1st St, Mineola, NY 11501 in Nassau County. The practice phone is (516) 663-0333.

Patricia Cherasard's primary practice is NYU Langone Hospitals - Long Island in Mineola, New York. The medical group on file is NYU Langone Orthopedic Surgery Associates. Dmand AI also links Patricia Cherasard to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Patricia Cherasard practices. Vendor and product names are available with a free account.

Surgical is Patricia Cherasard's primary specialty in the NPI Registry, under taxonomy code 363AS0400X. Patricia Cherasard is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Patricia Cherasard is licensed in New York.

Dmand AI lists arthritis among the conditions Patricia Cherasard treats.

CMS data shows 59 Medicare services from Patricia Cherasard across 1 procedure code in 2024, all of them office visits, for 34 Medicare patients. Medicare paid $4,126 for them. Every service was in an office.

CMS counts 34 Medicare patients who saw Patricia Cherasard in 2024. The largest group is 65 to 74, with 16 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Patricia Cherasard's median patient age at 47, with 81% women.

In 2024, Patricia Cherasard wrote 172 Medicare Part D claims for 57 patients. 37% of them were for generic drugs. CMS names the drug for 130 of them, across 6 drugs with 11 or more claims each, at $128,690 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Patricia Cherasard for performance year 2024, reported as part of a group. Patricia Cherasard accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Patricia Cherasard as offering telehealth.

Dmand AI links 2 papers to Patricia Cherasard. The most frequent topics are Obesity, Morbid. Patricia Cherasard's most frequent co-authors are Collin E M Brathwaite, MD, Venkata Krishnam Naidu Kella, MD and Jun Levine, MD.

CMS Open Payments shows 11 general payments to Patricia Cherasard from 4 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $228.